Vitalibis, Inc. (VCBDQ)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Vitalibis, Inc. (VCBDQ) with AI Score 61/100 (Hold). Vitalibis, Inc. is a technology-based formulator of phytocannabinoid-rich hemp products, personal care items, and nutritional products. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Vitalibis, Inc. (VCBDQ) Healthcare & Pipeline Overview
Vitalibis, Inc. formulates and markets phytocannabinoid-rich hemp products, personal care items, and nutritional products under the Vitalibis brand. Operating in the specialty and generic drug manufacturing sector, the company focuses on technology-based formulations and direct-to-consumer sales, including water-soluble hemp powder, differentiating itself through brand-building and specialized product offerings.
Investment Thesis
Vitalibis, Inc. presents a speculative investment opportunity within the high-growth CBD and hemp market. The company's focus on technology-based formulations and direct-to-consumer sales could drive revenue growth, although profitability remains a challenge, as evidenced by a negative profit margin of -2257.9%. Key value drivers include successful product innovation, effective marketing strategies to build brand awareness, and expansion into new distribution channels. The company's gross margin of 46.4% indicates potential for profitability if operating expenses are managed effectively. However, investors should be aware of the risks associated with OTC-listed companies, including limited liquidity and disclosure requirements. The company's beta of -0.46 suggests a low correlation with the overall market, which may offer some downside protection during market downturns.
Based on FMP financials and quantitative analysis
Key Highlights
- Vitalibis operates as a technology-based formulator of phytocannabinoid-rich hemp products.
- The company's gross margin stands at 46.4%, indicating potential for profitability with effective cost management.
- Vitalibis markets and sells consumer products under the Vitalibis brand, focusing on direct-to-consumer sales.
- The company's profit margin is -2257.9%, reflecting significant losses.
- Vitalibis's beta is -0.46, suggesting a low correlation with the overall market.
Competitors & Peers
Strengths
- Technology-based formulation capabilities.
- Established brand name (Vitalibis).
- Direct-to-consumer sales channel.
- Offers water-soluble hemp powder.
Weaknesses
- Negative profit margin (-2257.9%).
- Limited financial resources.
- OTC listing with lower liquidity.
- Small market capitalization.
Catalysts
- Potential regulatory changes in the CBD market could create new opportunities or challenges for Vitalibis.
- Increasing consumer awareness of CBD and hemp-derived products could drive demand for Vitalibis's products.
- Launch of new CBD-infused products could boost revenue and market share within the next year.
- Expansion of the direct-to-consumer sales channel could improve customer acquisition and retention.
Risks
- Intense competition in the CBD market could erode Vitalibis's market share and profitability.
- Changing regulatory landscape for CBD products could negatively impact Vitalibis's operations.
- Negative profit margin (-2257.9%) raises concerns about the company's financial sustainability.
- Limited liquidity due to OTC listing could make it difficult to buy or sell shares.
- Dependence on a single brand (Vitalibis) could make the company vulnerable to negative publicity or changing consumer preferences.
Growth Opportunities
- Expansion of Product Line: Vitalibis can expand its product line to include a wider range of CBD-infused products, such as edibles, topicals, and beverages. The global CBD market is projected to reach $55.79 billion by 2028, presenting a significant opportunity for Vitalibis to capture a larger share of the market. Successful product innovation and diversification could drive revenue growth and increase brand recognition.
- Strategic Partnerships: Forming strategic partnerships with established retailers, distributors, or healthcare providers could significantly expand Vitalibis's reach and market penetration. Collaborations with wellness centers, spas, or fitness studios could provide access to new customer segments and enhance brand credibility. These partnerships could be established within the next 1-2 years, providing a near-term growth catalyst.
- International Expansion: Expanding into international markets, particularly in Europe and Asia, could unlock significant growth potential for Vitalibis. These regions are experiencing increasing demand for CBD products, driven by changing consumer preferences and evolving regulatory frameworks. Successful international expansion would require careful market research, regulatory compliance, and adaptation of product offerings to local preferences. This expansion could be pursued over the next 3-5 years.
- Development of Proprietary Formulations: Investing in research and development to create proprietary CBD formulations with enhanced efficacy and bioavailability could provide a significant competitive advantage for Vitalibis. Developing patented or patent-pending formulations would differentiate the company's products from competitors and create barriers to entry. This could involve collaborations with research institutions or universities and could yield results within the next 2-3 years.
- Direct-to-Consumer (DTC) Optimization: Enhancing the company's direct-to-consumer sales channel through improved website design, targeted marketing campaigns, and personalized customer experiences could drive revenue growth and improve customer loyalty. Investing in data analytics and customer relationship management (CRM) systems could enable Vitalibis to better understand customer preferences and tailor its offerings accordingly. These improvements could be implemented within the next 6-12 months, providing a short-term boost to sales.
Opportunities
- Expansion of product line.
- Strategic partnerships with retailers and distributors.
- International market expansion.
- Development of proprietary formulations.
Threats
- Intense competition in the CBD market.
- Changing regulatory landscape for CBD products.
- Fluctuations in raw material prices.
- Potential for negative publicity or consumer backlash.
Competitive Advantages
- Brand recognition through the Vitalibis brand.
- Technology-based formulation expertise.
- Direct-to-consumer sales channel.
About VCBDQ
Vitalibis, Inc., founded in 2014 and headquartered in Las Vegas, Nevada, operates as a technology-based formulator of phytocannabinoid-rich hemp products containing cannabidiol (CBD). The company develops, markets, and sells a range of consumer products under the Vitalibis brand, focusing on personal care and nutritional supplements. In addition to finished goods, Vitalibis also offers water-soluble phytocannabinoid-rich hemp powder, catering to both individual consumers and potential business partners. Originally named Sheng Ying Entertainment Corp., the company rebranded as Vitalibis, Inc. in February 2018, signaling a strategic shift towards the burgeoning hemp and CBD market. Vitalibis aims to capitalize on the growing demand for hemp-derived products by offering innovative formulations and a direct-to-consumer sales model. The company's focus on technology-driven product development and brand-building positions it within the competitive landscape of the specialty and generic drug manufacturing industry, specifically targeting the niche market of CBD and hemp-based wellness products.
What They Do
- Formulates phytocannabinoid-rich hemp products.
- Develops personal care products.
- Creates nutritional products.
- Markets and sells consumer products under the Vitalibis brand.
- Sells water-soluble phytocannabinoid-rich hemp powder.
- Focuses on technology-based product development.
Business Model
- Develops and formulates CBD-infused products.
- Markets products directly to consumers through its Vitalibis brand.
- Sells water-soluble hemp powder to businesses and consumers.
Industry Context
Vitalibis, Inc. operates within the rapidly evolving market for CBD and hemp-derived products. This sector has experienced substantial growth in recent years, driven by increasing consumer awareness of the potential health benefits of CBD and changing regulatory landscapes. However, the industry is also characterized by intense competition, with numerous companies vying for market share. Vitalibis competes with both established players in the pharmaceutical and wellness industries and smaller, niche brands. The regulatory environment remains uncertain, with ongoing debates about the legality and safety of CBD products, which could impact the company's future growth prospects.
Key Customers
- Individual consumers seeking CBD-based wellness products.
- Customers interested in personal care and nutritional supplements.
- Businesses that utilize water-soluble hemp powder in their products.
Financials
Chart & Info
Vitalibis, Inc. (VCBDQ) stock price: Price data unavailable
Latest News
No recent news available for VCBDQ.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VCBDQ.
Price Targets
Wall Street price target analysis for VCBDQ.
MoonshotScore
What does this score mean?
The MoonshotScore rates VCBDQ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Leadership: Steven P. Raack
CEO
Steven P. Raack serves as the Chief Executive Officer of Vitalibis, Inc. His background includes experience in executive leadership and strategic management. He has been involved in guiding the company's strategic direction and overseeing its operations. His expertise lies in business development, marketing, and sales, with a focus on driving revenue growth and building brand awareness. He is responsible for setting the company's vision and ensuring its execution.
Track Record: Under Steven P. Raack's leadership, Vitalibis, Inc. has focused on developing and marketing phytocannabinoid-rich hemp products. Key milestones include the rebranding of the company from Sheng Ying Entertainment Corp. to Vitalibis, Inc. and the launch of the Vitalibis brand. He has overseen the company's efforts to establish a direct-to-consumer sales channel and expand its product offerings.
VCBDQ OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Vitalibis, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial disclosures, increasing the risk for investors due to lack of transparency and potential for price manipulation. Investing in OTC Other stocks requires careful due diligence and an understanding of the associated risks compared to stocks listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to low trading volume.
- Lack of regular financial disclosures.
- Potential for price manipulation.
- Higher price volatility compared to exchange-listed stocks.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if available).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with the OTC market.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Review the company's website and investor relations materials.
- Company has a registered business address and contact information.
- The company has a functional website with product information.
- The company has been in operation for several years.
- The company has a CEO and management team listed.
Common Questions About VCBDQ (Healthcare)
What does Vitalibis, Inc. do?
Vitalibis, Inc. operates as a technology-based formulator, developer, and marketer of phytocannabinoid-rich hemp products, personal care items, and nutritional products. The company focuses on leveraging the growing market for CBD-infused products by offering a range of consumer goods under its Vitalibis brand. In addition to finished products, Vitalibis also sells water-soluble phytocannabinoid-rich hemp powder, catering to both individual consumers and potential business partners. The company's business model centers around direct-to-consumer sales and brand-building within the competitive CBD and wellness market.
What do analysts say about VCBDQ stock?
As of 2026-03-16, formal analyst coverage of Vitalibis, Inc. (VCBDQ) is limited, likely due to its OTC listing and small market capitalization. Key valuation metrics, such as the P/E ratio (-0.00), reflect the company's current lack of profitability. Growth considerations revolve around the company's ability to expand its product line, increase brand awareness, and navigate the evolving regulatory landscape for CBD products. Investors should conduct their own thorough research and consider the risks associated with OTC-listed stocks before making any investment decisions.
What are the main risks for VCBDQ?
The main risks for Vitalibis, Inc. include intense competition in the rapidly growing CBD market, which could pressure pricing and erode market share. The evolving regulatory landscape for CBD products poses another significant risk, as changes in regulations could impact the legality and marketability of the company's products. The company's negative profit margin (-2257.9%) raises concerns about its financial sustainability and ability to generate positive cash flow. As an OTC-listed stock, VCBDQ also faces risks related to limited liquidity and disclosure requirements.
What are the key factors to evaluate for VCBDQ?
Vitalibis, Inc. (VCBDQ) currently holds an AI score of 61/100, indicating moderate score. Key strength: Technology-based formulation capabilities. Primary risk to monitor: Intense competition in the CBD market could erode Vitalibis's market share and profitability. This is not financial advice.
How frequently does VCBDQ data refresh on this page?
VCBDQ prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven VCBDQ's recent stock price performance?
Recent price movement in Vitalibis, Inc. (VCBDQ) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Technology-based formulation capabilities. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider VCBDQ overvalued or undervalued right now?
Determining whether Vitalibis, Inc. (VCBDQ) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying VCBDQ?
Before investing in Vitalibis, Inc. (VCBDQ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recently available information.
- The OTC market is inherently more volatile and risky than major exchanges.
- AI analysis is pending and may provide further insights.